Inovio Pharmaceuticals, Inc.
INO
$1.31
-$0.01-0.68%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 36.67M | 37.68M | 58.51M | 50.80M | 47.55M |
| Total Receivables | -- | -- | 500.00 | 978.60K | 840.30K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.24M | 1.76M | 2.61M | 3.40M | 4.31M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 39.91M | 39.44M | 61.12M | 55.18M | 52.70M |
|
|
|||||
| Total Current Assets | 39.91M | 39.44M | 61.12M | 55.18M | 52.70M |
| Net Property, Plant & Equipment | 7.56M | 8.33M | 9.07M | 9.70M | 10.45M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.92M | 2.01M | 2.01M | 2.01M | 2.01M |
| Total Assets | 49.39M | 49.78M | 74.31M | 69.39M | 68.24M |
|
|
|||||
| Total Accounts Payable | 3.64M | 1.99M | 2.62M | 5.90M | 5.48M |
| Total Accrued Expenses | 8.35M | 8.10M | 9.16M | 10.76M | 12.15M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.90M | 2.91M | 2.82M | 2.74M | 2.66M |
| Total Finance Division Other Current Liabilities | 25.02M | 24.93M | 29.07M | 50.43M | 11.42M |
| Total Other Current Liabilities | 25.02M | 24.93M | 29.07M | 50.43M | 11.42M |
| Total Current Liabilities | 39.92M | 37.92M | 43.67M | 69.82M | 31.71M |
|
|
|||||
| Total Current Liabilities | 39.92M | 37.92M | 43.67M | 69.82M | 31.71M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.10M | 5.79M | 6.55M | 7.28M | 8.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 45.02M | 43.71M | 50.21M | 77.11M | 39.71M |
|
|
|||||
| Common Stock & APIC | 1.85B | 1.84B | 1.84B | 1.81B | 1.80B |
| Retained Earnings | -1.84B | -1.83B | -1.82B | -1.82B | -1.77B |
| Treasury Stock & Other | -280.00K | -636.10K | -638.00K | -647.40K | -661.70K |
| Total Common Equity | 4.37M | 6.07M | 24.10M | -7.72M | 28.53M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.37M | 6.07M | 24.10M | -7.72M | 28.53M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.37M | 6.07M | 24.10M | -7.72M | 28.53M |
|
|
|||||